Viewing Study NCT01041833


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-04-15 @ 5:01 PM
Study NCT ID: NCT01041833
Status: UNKNOWN
Last Update Posted: 2010-01-01
First Post: 2009-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker
Sponsor: National Institute of Cancerología
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: CA/141/CB/563/09
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Oscar Arrieta, M.D.
Old Organization: Department of Medical Oncology, Instituto Nacional de Cancerología

Collaborators